Electroacupuncture Attenuates Fibromyalgia Pain Through Increased PD-1 Expression in Female Mice

Area of Science:

• Neuroscience
• Pain Research
• Immunology

Background:

• Fibromyalgia is a chronic pain condition with limited diagnostic and treatment options.
• Programmed cell death ligand 1 (PD-L1) plays a role in inhibiting pain signaling.

Purpose of the Study:

• To investigate the pain-relieving effects and mechanisms of PD-L1/PD1 in a mouse model of fibromyalgia.
• To explore electroacupuncture (EA) as a potential treatment modality.

Main Methods:

• Developed a fibromyalgia mouse model using intermittent cold stress.
• Administered EA or intraventricular PD-L1.
• Assessed pain behaviors using Von Frey and Hargreaves tests.
• Analyzed PD-1 levels and pain-related kinases via Western blot.
• Examined the role of microglia, astrocytes, and Toll-like receptor 4.

Main Results:

• The fibromyalgia model displayed mechanical and thermal hyperalgesia.
• EA and PD-L1 treatment reduced pain responses and PD-1 levels across brain regions and spinal cord.
• Fibromyalgia induction increased pain-related kinases, which were normalized by EA and PD-L1.
• Treatment inhibited microglia/astrocyte activation and Toll-like receptor 4 signaling.

Conclusions:

• EA effectively treats fibromyalgia pain in mice by modulating the PD-L1/PD1 pathway.
• The PD-L1/PD1 pathway represents a promising therapeutic target for fibromyalgia.